Vascular involvement in systemic sclerosis (scleroderma)

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y. I., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,716 · see citing works

Bosentan Therapy for Pulmonary Arterial Hypertension

Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., KEOGH, A. M., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,718 · see citing works

Molecular regulation of vessel maturation

Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,515 · see citing works

Inhaled Iloprost for Severe Pulmonary Hypertension

Olschewski, H., Simonneau, G., Galiè, N., HIGENBOTTAM, T. W., Naeije, R., Rubin, L. J., Nikkho, S. M., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,778 · see citing works

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Channick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,529 · see citing works

Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes

Albert, M. L., Pearce, S. F. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., & Bhardwaj, N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1359 · Cited by 1,234 · see citing works

Pathologic observations in systemic sclerosis (scleroderma)

D’Angelo, W., Fries, J. F., Masi, A. T., & SHULMAN, L. E. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90044-8 · Cited by 1,102 · see citing works

Tadalafil Therapy for Pulmonary Arterial Hypertension

Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,096 · see citing works

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

Badesch, D. B., Tapson, V. F., McGoon, M. D., Brundage, B. H., Rubin, L. J., Wigley, F. M., Rich, S., Barst, R. J., Barrett, P. S., Kral, K. M., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-6-200003210-00002 · Cited by 1,071 · see citing works

Reversal of experimental pulmonary hypertension by PDGF inhibition

SCHERMULY, R. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24838 · Cited by 1,059 · see citing works

The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1

Serini, G., Bochaton-Piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L., & Gabbiani, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.873 · Cited by 847 · see citing works

The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak

Tager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., Karimi-Shah, B. A., Kim, N. D., et al. (2008) · Nature Medicine · doi:10.1038/nm1685 · Cited by 823 · see citing works

Pericytes in the microvasculature

Hirschi, K. K., & D'Amore, P. A. (1996) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00063-6 · Cited by 763 · see citing works

Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist

Korn, J. H., Mayes, M. D., Matucci‐Cerinic, M., Rainisio, M., Pope, J. E., HACHULLA, E., Rich, E., Carpentier, P., Molitor, J. A., Seibold, J. R., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20676 · Cited by 722 · see citing works

Sitaxsentan Therapy for Pulmonary Arterial Hypertension

Barst, R. J., Langleben, D., Frost, A., Horn, E. M., Oudiz, R. J., Shapiro, S., McLaughlin, V. V., Hill, N. S., Tapson, V. F., Robbins, I. M., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-957oc · Cited by 706 · see citing works

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

Kowal‐Bielecka, O., Landewé, R., Avouac, J., Chwieśko-Minarowska, S., Miniati, I., Czirják, L., Clements, P. J., Denton, C. P., Farge, D., Fligelstone, K., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096677 · Cited by 617 · see citing works

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis

Koenig, M., Joyal, F., Fritzler, M. J., Roussin, A., Abrahamowicz, M., Boire, G., Goulet, J., Rich, E., Grodzicky, T., Raymond, Y., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24038 · Cited by 608 · see citing works

Latent Transforming Growth Factor β-binding Protein 1 Interacts with Fibrillin and Is a Microfibril-associated Protein

Isogai, Z., Ono, R. N., Ushiro, S., Keene, D. R., Chen, Y., Mazzieri, R., Charbonneau, N. L., Reinhardt, D. P., Rifkin, D. B., & Sakai, L. Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209256200 · Cited by 548 · see citing works

Increased Collagen Synthesis by Scleroderma Skin Fibroblasts In Vitro A POSSIBLE DEFECT IN THE REGULATION OR ACTIVATION OF THE SCLERODERMA FIBROBLAST

LeRoy, E. C. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107827 · Cited by 543 · see citing works

Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4

Postlethwaite, A. E., Holness, M. A., Katai, H., & Raghow, R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116015 · Cited by 504 · see citing works

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

Matucci‐Cerinic, M., Denton, C. P., Furst, D. E., Mayes, M. D., Hsu, V. M., Carpentier, P., Wigley, F. M., Black, C. M., Fessler, B. J., Merkel, P. A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.130658 · Cited by 494 · see citing works

Imatinib for the Treatment of Pulmonary Arterial Hypertension

Ghofrani, H. A., Seeger, W., & Grimminger, F. (2005) · New England Journal of Medicine · doi:10.1056/nejmc051946 · Cited by 492 · see citing works

Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan

Barst, R. J., Langleben, D., Badesch, D. B., Frost, A., Lawrence, E. C., Shapiro, S., Naeije, R., & Galiè, N. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.057 · Cited by 478 · see citing works

Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension

Perros, F., Montani, D., Dorfmüller, P., Durand–Gasselin, I., Tchérakian, C., Pavec, J. L., Mazmanian, M. G., Fadel, É., Mussot, S., Mercier, O. M., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1037oc · Cited by 471 · see citing works

Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.

Raghow, R., Postlethwaite, A. E., Keski‐Oja, J., Moses, H. L., & Kang, A. H. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112950 · Cited by 461 · see citing works

Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice

Zhao, Y., Liu, Y., Stan, R. V., Fan, L., Gu, Y., Dalton, N. D., Chu, P.-H., Peterson, K. L., Ross, J., & Chien, K. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172360799 · Cited by 448 · see citing works

Outcome of Renal Crisis in Systemic Sclerosis: Relation to Availability of Angiotensin Converting Enzyme (ACE) Inhibitors

Steen, V. D., Costantino, J. P., Shapiro, A. P., & Medsger, T. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-5-352 · Cited by 436 · see citing works

Scleroderma renal crisis: patient characteristics and long-term outcomes

Penn, H., Howie, A. J., Kingdon, E., Bunn, C. C., Stratton, R. J., Black, C. M., Burns, A. P., & Denton, C. P. (2007) · QJM · doi:10.1093/qjmed/hcm052 · Cited by 427 · see citing works

Pathogenesis of systemic sclerosis: A vascular hypothesis

Campbell, P. M., & LeRoy, E. C. (1975) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(75)90017-7 · Cited by 410 · see citing works

Identification of PLOD2 as Telopeptide Lysyl Hydroxylase, an Important Enzyme in Fibrosis

van der Slot, A. J., Zuurmond, A., Bardoel, A. F. J., Wijmenga, C., Pruijs, H. E. H., Sillence, D. O., Brinckmann, J., Abraham, D., Black, C. M., Verzijl, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307380200 · Cited by 410 · see citing works

Pathogenesis of Raynaud's phenomenon

Herrick, A. L. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/keh552 · Cited by 409 · see citing works

Systemic and cell type-specific gene expression patterns in scleroderma skin

Whitfield, M. L., Finlay, D. R., Murray, J. I., Troyanskaya, O. G., Chi, J., Pergamenschikov, A., McCalmont, T. H., Brown, P. O., Botstein, D., & Connolly, M. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635114100 · Cited by 408 · see citing works

Sequential dermal microvascular and perivascular changes in the development of scleroderma

Prescott, R. J., Freemont, A. J., Jones, C. J. P., Hoyland, J. A., & Fielding, P. (1992) · The Journal of Pathology · doi:10.1002/path.1711660307 · Cited by 388 · see citing works

Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin

Milano, A., Pendergrass, S. A., Sargent, J. L., George, L. K., McCalmont, T. H., Connolly, M. K., & Whitfield, M. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002696 · Cited by 384 · see citing works

Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.

Sgonc, R., Gruschwitz, M. S., Dietrich, H., Recheis, H., Gershwin, M. E., & Wick, G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118851 · Cited by 373 · see citing works

Pulmonary hypertension in the crest syndrome variant of systemic sclerosis

Stupi, A. M., Steen, V. D., Owens, G. R., Barnes, E. L., Rodnan, G. P., & Medsger, T. A. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290409 · Cited by 366 · see citing works

Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases

Dorfmüller, P., Humbert, M. J. C., Perros, F., Sanchez, O., Simonneau, G., Müller, K., & Capron, F. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.11.022 · Cited by 341 · see citing works

The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR

Liu, G., Burns, S., Huang, G., Boyd, K., Proia, R. L., Flavell, R. A., & Chi, H. (2009) · Nature Immunology · doi:10.1038/ni.1743 · Cited by 339 · see citing works

The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells

Gargalovic, P. S., Gharavi, N. M., Clark, M. J., Pagnon, J. C., Yang, W.-P., He, A., Truong, A. B., Baruch-Oren, T., Berliner, J. A., Kirchgessner, T. G., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000242903.41158.a1 · Cited by 338 · see citing works

THE RELATIONSHIP OF HYPERTENSION AND RENAL FAILURE IN SCLERODERMA (PROGRESSIVE SYSTEMIC SCLEROSIS) TO STRUCTURAL AND FUNCTIONAL ABNORMALITIES OF THE RENAL CORTICAL CIRCULATION

Cannon, P., Hassar, M., Case, D. B., Casarella, W. J., Sommers, S. C., & LeRoy, E. C. (1974) · Medicine · doi:10.1097/00005792-197401000-00001 · Cited by 337 · see citing works

Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil

Barst, R. J., Galiè, N., Naeije, R., Simonneau, G., Jeffs, R., Arneson, C. P., & Rubin, L. J. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00044406 · Cited by 337 · see citing works

Sildenafil in the Treatment of Raynaud’s Phenomenon Resistant to Vasodilatory Therapy

Fries, R., Shariat, K., Wilmowsky, H., & Böhm, M. (2005) · Circulation · doi:10.1161/circulationaha.104.523324 · Cited by 333 · see citing works

Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis

́stergaard, M., Hansen, M. S., Stoltenberg, M., Gideon, P., Klarlund, M., Jensen, K. E., & Lorenzen, I. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5 · Cited by 323 · see citing works

Long-Term Outcomes of Scleroderma Renal Crisis

Steen, V. D., & Medsger, T. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00010 · Cited by 322 · see citing works

Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells

Sato, S., Fujimoto, M., Hasegawa, M., & Takehara, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20274 · Cited by 317 · see citing works

Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis

Distler, O., Distler, J. H. W., Scheid, A., Acker, T., Hirth, A., Rethage, J., Michel, B. A., Gay, R. E., Müller-Ladner, U., Matucci-Cerinic, M., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000134644.89917.96 · Cited by 310 · see citing works

Vascular Disease in Progressive Systemic Sclerosis (Scleroderma)

Norton, W. L., & NARDO, J. M. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-2-317 · Cited by 303 · see citing works

Diverse Contribution of Bone Marrow Cells to Neointimal Hyperplasia After Mechanical Vascular Injuries

Tanaka, K., Sata, M., Hirata, Y., & Nagai, R. (2003) · Circulation Research · doi:10.1161/01.res.0000096651.13001.b4 · Cited by 298 · see citing works

Cross Talk Between Endothelial and Smooth Muscle Cells in Pulmonary Hypertension

Eddahibi, S., Guignabert, C., Barlier‐Mur, A., Dewachter, L., Fadel, É., Dartevelle, P., Humbert, M. J. C., Simonneau, G., Hanoun, N., Saurini, F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.591321 · Cited by 296 · see citing works

Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis

Jiménez, S. A., & Derk, C. T. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00010 · Cited by 296 · see citing works

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

Distler, O., Rosso, A. D., Giacomelli, R., Cipriani, P., Conforti, M. L., Guiducci, S., Gay, R. E., Michel, B. A., Brühlmann, P., Müller‐Ladner, U., et al. (2002) · Arthritis Research & Therapy · doi:10.1186/ar596 · Cited by 279 · see citing works

Defective vasculogenesis in systemic sclerosis

Kuwana, M., Okazaki, Y., Yasuoka, H., Kawakami, Y., & Ikeda, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16853-0 · Cited by 279 · see citing works

Significant Correlation Between Connective Tissue Growth Factor Gene Expression and Skin Sclerosis in Tissue Sections from Patients with Systemic Sclerosis

Igarashi, A., Nashiro, K., Kikuchi, K., Sato, S., Ihn, H., Grotendorst, G. R., & Takehara, K. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12318465 · Cited by 275 · see citing works

Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection

Cool, C. D., Kennedy, D., Voelkel, N. F., & Tuder, R. M. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90032-0 · Cited by 263 · see citing works

Treprostinil, a Prostacyclin Analogue, in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

Oudiz, R. J., Schilz, R. J., Barst, R. J., Galiè, N., Rich, S., Rubin, L. J., & Simonneau, G. (2004) · CHEST Journal · doi:10.1378/chest.126.2.420 · Cited by 263 · see citing works

Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling

Gabbiani, G., & Hinz, B. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-05-0328 · Cited by 260 · see citing works

Shed Membrane Particles From T Lymphocytes Impair Endothelial Function and Regulate Endothelial Protein Expression

Martin, S., Tesse, A., Hugel, B., Martínez, M. C., Morel, O., Freyssinet, J., & Andriantsitohaina, R. (2004) · Circulation · doi:10.1161/01.cir.0000124065.31211.6e · Cited by 245 · see citing works

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

Rajkumar, V. S., Howell, K., Csiszar, K., Denton, C. P., Black, C. M., & Abraham, D. J. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1790 · Cited by 242 · see citing works

Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome

Loeys, B., Gerber, E. E., Riegert‐Johnson, D. L., Iqbal, S., Whiteman, P., McConnell, V. P. M., Chillakuri, C., Macaya, D., Coucke, P. J., Paepe, A. D., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000488 · Cited by 239 · see citing works

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era

Williams, M. H. (2005) · Heart · doi:10.1136/hrt.2005.069484 · Cited by 236 · see citing works

Endothelin, an endothelial‐dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action

Kahaleh, M. B. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340807 · Cited by 234 · see citing works

Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

Sato, S., Nagaoka, T., Hasegawa, M., Tamatani, T., Nakanishi, T., Takigawa, M., & Takehara, K. (2000) · PubMed · Cited by 233 · see citing works

Rho Kinase Mediates Cold-Induced Constriction of Cutaneous Arteries

Bailey, S. R., Eid, A. H., Mitra, S., Flavahan, S., & Flavahan, N. A. (2004) · Circulation Research · doi:10.1161/01.res.0000128407.45014.58 · Cited by 231 · see citing works

Endothelial Atheroprotective and Anti‐inflammatory Mechanisms

Berk, B. C., Abe, J., Wang, M., Surapisitchat, J., & Chen, Y. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03932.x · Cited by 230 · see citing works

Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial

Barnett, M. L., Kremer, J. M., Clair, E. W. S., Clegg, D. O., Furst, D. E., Weisman, M. H., Fletcher, M., Chasan-Taber, S., Finger, E., Morales, A., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199802)41:2 · Cited by 227 · see citing works

The Association of Progressive Systemic Sclerosis (Scleroderma) with Coal Miners' Pneumoconiosis and Other Forms of Silicosis

Rodnan, G. P., BENEDEK, T. G., MEDSGER, T. A., & CAMMARATA, R. J. (1967) · Annals of Internal Medicine · doi:10.7326/0003-4819-66-2-323 · Cited by 227 · see citing works

Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis

Thompson, A., & Pope, J. E. (2004) · Lara D. Veeken · doi:10.1093/rheumatology/keh390 · Cited by 224 · see citing works

Circulating Bone Marrow Cells Can Contribute to Neointimal Formation

Han, C., CAMPBELL, G. R., & CAMPBELL, G. R. (2001) · Journal of Vascular Research · doi:10.1159/000051038 · Cited by 224 · see citing works

Increased Factor VIII/von Willebrand Factor Antigen and von Willebrand Factor Activity in Scleroderma and in Raynaud's Phenomenon

Kahaleh, M. B., OSBORN, I., & LeROY, E. C. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-4-482 · Cited by 222 · see citing works

Cellular and molecular aspects of vascular dysfunction in systemic sclerosis

Trojanowska, M. E. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.102 · Cited by 216 · see citing works

Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.

Badesch, D. B., Hill, N. S., Burgess, G., Rubin, L. J., Barst, R. J., Galiè, N., & Simonneau, G. (2007) · PubMed · Cited by 216 · see citing works

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls

Arnett, F. C., Gourh, P., Shete, S. S., Ahn, C. W., Honey, R., Agarwal, S. K., Tan, F. K., McNearney, T. A., Fischbach, M., Fritzler, M. J., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.111906 · Cited by 215 · see citing works

Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation

Piconese, S., Gri, G., Tripodo, C., Musio, S., Gorzanelli, A., Frossi, B., Pedotti, R., Pucillo, C. E. M., & Colombo, M. P. (2009) · Blood · doi:10.1182/blood-2009-05-220004 · Cited by 211 · see citing works

Connective tissue growth factor: A new and important player in the pathogenesis of fibrosis

Leask, A., Holmes, A. M., & Abraham, D. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0009-x · Cited by 210 · see citing works

Oligoclonal T Cell Expansion in the Skin of Patients with Systemic Sclerosis

Sakkas, L. I., Xu, B., Artlett, C. M., Lu, S., Jiménez, S. A., & Platsoucas, C. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3649 · Cited by 204 · see citing works

Serotonin Transporter Inhibitors Protect against Hypoxic Pulmonary Hypertension

Marcos, É., Adnot, S., Pham, M. H., Nosjean, A., Raffestin, B., Hamon, M., & Eddahibi, S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1212oc · Cited by 203 · see citing works

LPA1 Receptor Activation Promotes Renal Interstitial Fibrosis

Pradère, J., Klein, J., Accent]s, S. G. G., Accent], C. G. A., Neau, E., Valet, P., Calise, D., Chun, J. J. M., Bascands, J., Saulnier‐Blache, J. S., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020196 · Cited by 202 · see citing works

Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation

Zhang, C., Baker, D. L., Yasuda, S., Makarova, N., Balázs, L., Johnson, L. R., Marathe, G. K., McIntyre, T. M., Xu, Y., Prestwich, G. D., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031619 · Cited by 202 · see citing works

Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?

Fleming, J. N., Nash, R. A., McLeod, D. O., Fiorentino, D. F., Shulman, H. M., Connolly, M. K., Molitor, J. A., Henstorf, G., Lafyatis, R., Pritchard, D. K., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001452 · Cited by 187 · see citing works

Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression

Radstake, T. R. D. J., van Bon, L., Broen, J. C. A., Wenink, M. H., Santegoets, K. C. M., Deng, Y., Hussaini, A., Simms, R. W., Cruikshank, W. W., & Lafyatis, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005981 · Cited by 185 · see citing works

Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis

Pope, J. E., Fenlon, D., Thompson, A. N., Shea, B., Furst, D. E., Wells, G. A., & Silman, A. J. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000953 · Cited by 179 · see citing works

The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes

Radstake, T. R. D. J., van Bon, L., Broen, J. C. A., Hussiani, A., Hesselstrand, R., Wuttge, D. M., Deng, Y., Simms, R., Lubberts, E., & Lafyatis, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005903 · Cited by 177 · see citing works

Raynaud's phenomenon: Pathogenesis and management

Bakst, R. L., Merola, J. F., Franks, A. G., & Sanchez, M. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.06.004 · Cited by 176 · see citing works

Bosentan therapy for pulmonary arterial hypertension

Rubin, L. J., Badesch, D. B., & Barst, R. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00782-1 · Cited by 176 · see citing works

Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis

Papa, N. D., Colombo, G. I., Fracchiolla, N., Mazzeo, L. M., Ingegnoli, F., Maglione, W., Comina, D. P., Vitali, C., Fantini, F., & Cortelezzi, A. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20116 · Cited by 173 · see citing works

Allergen Induces the Migration of Platelets to Lung Tissue in Allergic Asthma

Pitchford, S. C., Momi, S., Baglioni, S., Casali, L., Giannini, S., Rossi, R., Page, C. P., & Gresele, P. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-214oc · Cited by 169 · see citing works

Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts

Gardner, H., Shearstone, J. R., Bandaru, R., Crowell, T., Lynes, M. D., Trojanowska, M. E., Pannu, J., Smith, E. A., Jabłońska, S., Błaszczyk, M., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21894 · Cited by 167 · see citing works

Induction of interferon‐α by scleroderma sera containing autoantibodies to topoisomerase I: Association of higher interferon‐α activity with lung fibrosis

Kim, D., Peck, A., Santer, D. M., Patole, P. S., Schwartz, S. M., Molitor, J. A., Arnett, F. C., & Elkon, K. B. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23486 · Cited by 166 · see citing works

Decreased expression of caveolin 1 in patients with systemic sclerosis: Crucial role in the pathogenesis of tissue fibrosis

Galdo, F. D., Sotgia, F., de Almeida, C. J., Jasmin, J.-F., Musick, M., Lisanti, M. P., & Jiménez, S. A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23791 · Cited by 164 · see citing works

Pericytes as collagen-producing cells in excessive dermal scarring.

Sundberg, C., Ivarsson, M., Gerdin, B., & Rubin, K. (1996) · PubMed · Cited by 161 · see citing works

Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.

Abou‐Raya, A., Abou‐Raya, S., & Helmii, M. (2008) · PubMed · Cited by 159 · see citing works

Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis

Koch, A. E., & Distler, O. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2187 · Cited by 157 · see citing works

Significance of plasma endothelin-1 levels in patients with systemic sclerosis.

Yamane, K., Miyauchi, T., Suzuki, N., Yuhara, T., Akama, T., Suzuki, H., & Kashiwagi, H. (1992) · PubMed · Cited by 157 · see citing works

Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo

Tourkina, E., Richard, M., Göőz, P., Bonner, M., Pannu, J., Harley, R. A., Bernatchez, P. N., Sessa, W. C., Silver, R. M., & Hoffman, S. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00295.2007 · Cited by 153 · see citing works

Impairment of endothelial cell differentiation from bone marrow–derived mesenchymal stem cells: New insight into the pathogenesis of systemic sclerosis

Cipriani, P., Guiducci, S., Miniati, I., Cinelli, M., Urbani, S., Marrelli, A., Dolo, V., Pavan, A., Saccardi, R., Tyndall, A., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22698 · Cited by 152 · see citing works

Imatinib Mesylate in the Treatment of Refractory Idiopathic Pulmonary Arterial Hypertension

Patterson, K. C., Weissmann, A., Ahmadi, T., & Farber, H. W. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-2-200607180-00020 · Cited by 148 · see citing works

Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor- -stimulated collagen production by cardiac fibroblasts

Lowe, N. G., Swaney, J. S., Moreno, K. M., & Sabbadini, R. A. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp056 · Cited by 147 · see citing works

Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis

Matucci‐Cerinic, M., Valentini, G., Sorano, G. G., D’Angelo, S., Cuomo, G., Fenu, L., Generini, S., Cinotti, S., Morfini, M., Pignone, A. M., et al. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.50011 · Cited by 145 · see citing works

Apoptosis is associated with increased cell surface tissue factor procoagulant activity.

Greeno, E. W., Bach, R. R., & Moldow, C. F. (1996) · PubMed · Cited by 144 · see citing works

Capillary alterations in scleroderma

Fleischmajer, R., & Perlish, J. S. (1980) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(80)80396-3 · Cited by 143 · see citing works

Presence of CD4+CD8+ double‐positive T cells with very high interleukin‐4 production potential in lesional skin of patients with systemic sclerosis

Parel, Y., Aurrand‐Lions, M., Scheja, A., Dayer, J., Roosnek, E. E., & Chizzolini, C. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22927 · Cited by 139 · see citing works

Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122.

Postlethwaite, A. E., & Seyer, J. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115247 · Cited by 139 · see citing works

Role of endothelin in fibrosis and anti‐fibrotic potential of bosentan

Clozel, M., & Salloukh, H. (2005) · Annals of Medicine · doi:10.1080/07853890410018925 · Cited by 135 · see citing works

Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis

Farina, G. A., York, M. R., Dimarzio, M., Collins, C., Meller, S., Homey, B., Rifkin, I. R., Marshak‐Rothstein, A., Radstake, T. R. D. J., & Lafyatis, R. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.200 · Cited by 133 · see citing works

Increased smooth muscle cell expression of caveolin‐1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension

Patel, H. H., Zhang, S., Murray, F., Suda, R. Y. S., Head, B. P., Yokoyama, U., Swaney, J. S., Niesman, I. R., SCHERMULY, R. T., Pullamsetti, S. S., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8424com · Cited by 130 · see citing works

Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis

Tokumura, A., Carbone, L. D., Yoshioka, Y., Morishige, J., Kikuchi, M., Postlethwaite, A. E., & Watsky, M. A. (2009) · International Journal of Medical Sciences · doi:10.7150/ijms.6.168 · Cited by 129 · see citing works

Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study

Brueckner, C., Becker, M. O., Kröncke, T. J., Huscher, D., Scherer, H. U., Worm, M., Burmester, G. R., & Riemekasten, G. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.116475 · Cited by 128 · see citing works

Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2

Ikeda, H., Watanabe, N., Ishii, I., Shimosawa, T., Kume, Y., Tomiya, T., Inoue, Y., Nishikawa, T., Ohtomo, N., Tanoue, Y., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800496-jlr200 · Cited by 125 · see citing works

Vascular Disease in Scleroderma: Mechanisms of Vascular Injury

Kahaleh, B. (2008) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2007.12.004 · Cited by 125 · see citing works

Localization of endothelin-1 and its binding sites in scleroderma skin.

Vancheeswaran, R., Azam, A., Black, C. M., & Dashwood, M. R. (1994) · PubMed · Cited by 125 · see citing works

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double‐blind, placebo‐controlled trial of the angiotensin‐converting enzyme inhibitor quinapril

GLIDDON, A. E., Doré, C. J., Black, C. M., McHugh, N. J., Moots, R., Denton, C. P., Herrick, A. L., Barnes, T. C., Camilleri, J., Chakravarty, K., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22965 · Cited by 123 · see citing works

Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?

HACHULLA, E., Launay, D., Mouthon, L., Sitbon, O., BEREZNE, A., Guillevin, L., Hatron, P., Simonneau, G., Clerson, P., & Humbert, M. J. C. (2009) · CHEST Journal · doi:10.1378/chest.08-3042 · Cited by 123 · see citing works

Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.

Herrick, A. L., Illingworth, K., Blann, A. D., Hay, C. R. M., Hollis, S., & Jayson, M. I. V. (1996) · Annals of the Rheumatic Diseases · doi:10.1136/ard.55.2.122 · Cited by 122 · see citing works

Cutting Edge: Alternative Signaling of Th17 Cell Development by Sphingosine 1-Phosphate

Liao, J., Huang, M., & Goetzl, E. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5425 · Cited by 121 · see citing works

The Diagnosis and Treatment of??Raynaud???s Phenomenon

Pope, J. E. (2007) · Drugs · doi:10.2165/00003495-200767040-00003 · Cited by 120 · see citing works

Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon.

Blann, A. D., Illingworth, K., & Jayson, M. I. V. (1993) · PubMed · Cited by 117 · see citing works

Is systemic sclerosis an antigen‐driven T cell disease?

Sakkas, L. I., & Platsoucas, C. D. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20315 · Cited by 116 · see citing works

SUSTAINED-RELEASE TRANSDERMAL GLYCERYL TRINITRATE PATCHES AS A TREATMENT FOR PRIMARY AND SECONDARY RAYNAUD'S PHENOMENON

Teh, L., Manning, J., MOORE, T. L., Tully, M. P., O'REILLY, D., & Jayson, M. I. V. (1995) · Lara D. Veeken · doi:10.1093/rheumatology/34.7.636 · Cited by 116 · see citing works

Sphingosine-1-phosphate and modulation of vascular tone

Igarashi, J., & Michel, T. M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp064 · Cited by 115 · see citing works

TOPICAL GLYCERYL TRINITRATE AS ADJUNCTIVE TREATMENT IN RAYNAUD'S DISEASE

Franks, A. G. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90215-x · Cited by 114 · see citing works

MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trial

Chung, L. S., Shapiro, L. S., Fiorentino, D. F., Baron, M. G., Shanahan, J. C., Sule, S., Hsu, V. M., Rothfield, N. F., Steen, V. D., Martin, R. W., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24351 · Cited by 113 · see citing works

Abnormalities in the Regulators of Angiogenesis in Patients with Scleroderma

Hummers, L. K., Hall, A. E., Wigley, F. M., & Simons, M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080516 · Cited by 113 · see citing works

Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity

Watanabe, N., Ikeda, H., Nakamura, K., Ohkawa, R., Kume, Y., Tomiya, T., Tejima, K., Nishikawa, T., Arai, M., Yanase, M., et al. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.08.013 · Cited by 112 · see citing works

A multicenter, randomized, double‐blind, placebo‐controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late‐phase disease

Postlethwaite, A. E., Wong, W. K., Clements, P. J., Chatterjee, S., Fessler, B. J., Kang, A. H., Korn, J. H., Mayes, M. D., Merkel, P. A., Molitor, J. A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23501 · Cited by 110 · see citing works

Digital ulcers in patients with systemic sclerosis

Chung, L. S., & Fiorentino, D. F. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.08.004 · Cited by 109 · see citing works

The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis

Davies, C. A., Jeziorska, M., Freemont, A. J., & Herrick, A. L. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.10.007 · Cited by 108 · see citing works

Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine

Dooley, A., Gao, B., Bradley, N. J., Abraham, D., Black, C. M., Jacobs, M., & Bruckdorfer, K. R. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kei276 · Cited by 107 · see citing works

Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma

Hummers, L. K., & Wigley, F. M. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00019-x · Cited by 106 · see citing works

Lysophosphatidic acid and renal fibrosis

Pradère, J., Gonzalez, J., Klein, J., Valet, P., Grès, S., Salant, D. J., Bascands, J., Saulnier‐Blache, J. S., & Schanstra, J. P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.04.001 · Cited by 105 · see citing works

Future treatments in systemic sclerosis

Asano, Y. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00758.x · Cited by 103 · see citing works

SKIN CAPILLARIES IN SCLERODERMA

BROWN, G. E. (1925) · Archives of Internal Medicine · doi:10.1001/archinte.1925.00120130076008 · Cited by 102 · see citing works

Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis

Rustin, M. H. A., Bull, H. A., Ziegler, V., Mehlhorn, J., LHAUSTEIN, U., LMADDISON, P. J., James, J., & Dowd, P. M. (1990) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1990.tb04189.x · Cited by 99 · see citing works

Selective endothelinA receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease

Girgis, R. E., Frost, A., Hill, N. S., Horn, E. M., Langleben, D., McLaughlin, V. V., Oudiz, R. J., Robbins, I., Seibold, J. R., Shapiro, S., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.069609 · Cited by 99 · see citing works

Survival in patients with pulmonary arterial hypertension treated with first‐line bosentan

McLaughlin, V. V. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01688.x · Cited by 97 · see citing works

Statins: Potentially Useful in Therapy of Systemic Sclerosis-related Raynaud's Phenomenon and Digital Ulcers

THIERS, B. H. (2009) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(09)79298-6 · Cited by 95 · see citing works

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

Distler, J. H. W., Allanore, Y., Avouac, J., Giacomelli, R., Guiducci, S., Moritz, F., Akhmetshina, A., Walker, U. A., Gabrielli, A., Müller-Ladner, U., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091918 · Cited by 94 · see citing works

Predictors and Risk Factors for Recurrent Scleroderma Renal Crisis in the Kidney Allograft: Case Report and Review of the Literature

Pham, P. T., Pham, P. T., Danovitch, G. M., Gritsch, H. A., Singer, J. S., Wallace, W. D., Hayashi, R., & Wilkinson, A. H. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01035.x · Cited by 93 · see citing works

Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon

Bunker, C. B., Reavley, C., Dowd, P. M., & O’Shaughnessy, D. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91286-u · Cited by 92 · see citing works

Prazosin for Raynaud's phenomenon in progressive systemic sclerosis

Harding, S. E., Tingey, P. C., Pope, J. E., Fenlon, D., Furst, D. E., Shea, B., Silman, A. J., Thompson, A. N., & Wells, G. A. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000956 · Cited by 92 · see citing works

Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity

Avouac, J., Juin, F., Wipff, J., Couraud, P., Chiocchia, G., Kahan, A., Boileau, C., Uzan, G., & Allanore, Y. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.082131 · Cited by 91 · see citing works

Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum–Induced Apoptosis in Endothelial Progenitor Cells

Zhu, S., Evans, S., Yan, B., Povsic, T. J., Tapson, V. F., Goldschmidt‐Clermont, P. J., & Dong, C. (2008) · Circulation · doi:10.1161/circulationaha.108.787200 · Cited by 90 · see citing works

Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis

Kuwana, M., Kaburaki, J., Okazaki, Y., Yasuoka, H., Kawakami, Y., & Ikeda, Y. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21899 · Cited by 88 · see citing works

Involvement of Rho-Kinase in Agonists-Induced Contractions of Arteriosclerotic Human Arteries

Kandabashi, T., Shimokawa, H., Mukai, Y., Matoba, T., Kunihiro, I., Morikawa, K., Ito, M., Takahashi, S., Kaibuchi, K., & Takeshita, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.104274 · Cited by 87 · see citing works

Levels of circulating endothelial progenitor cells in systemic sclerosis.

Allanore, Y., Batteux, F., Avouac, J., Assous, N., Weill, B. J., & Kahan, A. (2007) · PubMed · Cited by 85 · see citing works

Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study.

Sambo, P., Amico, D., Giacomelli, R., Matucci‐Cerinic, M., Salsano, F., Valentini, G., & Gabrielli, A. (2001) · PubMed · Cited by 85 · see citing works

Skin capillary changes in early systemic scleroderma. Electron microscopy and "in vitro" autoradiography with tritiated thymidine

Fleischmajer, R. (1976) · Archives of Dermatology · doi:10.1001/archderm.112.11.1553 · Cited by 85 · see citing works

Different Pattern of Collagen Cross-Links in Two Sclerotic Skin Diseases: Lipodermatosclerosis and Circumscribed Scleroderma

Brinckmann, J., Gaber, Y., Gebker, R., Neess, C. M., Sobhi, H. A., Notbohm, H., Hunzelmann, N., Fietzek, P. P., Müller, P. K., Risteli, J., et al. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01414.x · Cited by 84 · see citing works

Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy

Freemont, A. J., Hoyland, J. A., Fielding, P., Hodson, N. W., & Jayson, M. I. V. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb00100.x · Cited by 84 · see citing works

The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome

Ames, P. R. J., Lupoli, S., Alves, J. D., Atsumi, T., Edwards, C., Iannaccone, L., Khamashta, M. A., Hughes, G. R., & Brancaccio, V. (1997) · Lara D. Veeken · doi:10.1093/rheumatology/36.10.1045 · Cited by 81 · see citing works

Innate immunity and inflammation in systemic sclerosis

Lafyatis, R., & York, M. R. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32832fd69e · Cited by 77 · see citing works

Platelet contributions to the pathogenesis of systemic sclerosis

Postlethwaite, A. E., & Chiang, T. M. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282eeb3a4 · Cited by 76 · see citing works

The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis

Asano, Y., Bujor, A. M., & Trojanowska, M. E. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.06.008 · Cited by 75 · see citing works

Efficacy and tolerability of a selective α2C‐adrenergic receptor blocker in recovery from cold‐induced vasospasm in scleroderma patients: A single‐center, double‐blind, placebo‐controlled, randomized crossover study

Wise, R. A., Wigley, F. M., White, B., Leatherman, G., Zhong, J., Krasa, H. B., Kambayashi, J., Orlandi, C., & Czerwiec, F. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20665 · Cited by 75 · see citing works

The Pathology of Scleroderma Vascular Disease

Fleming, J. N., & Schwartz, S. M. (2008) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2008.01.001 · Cited by 74 · see citing works

Long-term experience of bosentan for treating ulcers and healed ulcers in systemic sclerosis patients

de la Peña-Lefebvre, P. G., Rubio, S. R., Valero-Expósito, M., Carmona, L., Gámir, M. L. G., Gutiérrez, J. B., Díaz-Miguel, C., Martinez, J. O., & Mendoza, A. C. Z. (2007) · Lara D. Veeken · doi:10.1093/rheumatology/ken001 · Cited by 74 · see citing works

Antiangiogenic plasma activity in patients with systemic sclerosis

Mulligan‐Kehoe, M. J., Drinane, M. C., Mollmark, J. I., Casciola-Rosen, L. A., Hummers, L. K., Hall, A. E., Rosen, A., Wigley, F. M., & Simons, M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22861 · Cited by 73 · see citing works

Immunohistological Study of Endothelin-1 and Endothelin-A and B Receptors in Two Patients with Scleroderma Renal Crisis

Kobayashi, H., Nishimaki, T., Kaise, S., Suzuki, T., Watanabe, K., Kasukawa, R., & Suzuki, T. (1999) · Clinical Rheumatology · doi:10.1007/s100670050132 · Cited by 73 · see citing works

GEOGRAPHICAL CLUSTERING OF SCLERODERMA IN SOUTH AND WEST LONDON

Silman, A. J., HOWARD, Y., HICKLIN, A. J., & Black, C. M. (1990) · Lara D. Veeken · doi:10.1093/rheumatology/29.2.92 · Cited by 72 · see citing works

Relationship between underlying renal disease and renal transplantation outcome

Bleyer, A. J., Donaldson, L. A., McIntosh, M. J., & Adams, P. L. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.24516 · Cited by 72 · see citing works

Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud's phenomenon

Bunker, C. B., Goldsmith, P. C., Leslie, T. A., Hayes, N. A., Foreman, J. C., & Dowd, P. M. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.22757.x · Cited by 72 · see citing works

Understanding, assessing and treating Raynaudʼs phenomenon

Boin, F., & Wigley, F. M. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.bor.0000179944.35400.6e · Cited by 70 · see citing works

Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study.

Kawald, A., Burmester, G. R., Huscher, D., Sunderkötter, C. H., & Riemekasten, G. (2008) · PubMed · Cited by 69 · see citing works

The treatment with N-acetylcysteine of Raynaud’s phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients

Rosato, E., Borghese, F., Pisarri, S., & Salsano, F. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1251-7 · Cited by 67 · see citing works

Enhanced fibrillin-2 expression is a general feature of wound healing and sclerosis: potential alteration of cell attachment and storage of TGF-β

Brinckmann, J., Hunzelmann, N., Kahle, B. K., Rohwedel, J., Kramer, J., Gibson, M. A., Hubmacher, D., & Reinhardt, D. P. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.49 · Cited by 67 · see citing works

Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity.

Fiocco, U., Rosada, M., Cozzi, L., Ortolani, C., Silvestro, G. D., Ruffatti, A., Cozzi, E., Gallo, C., & TODESCO, S. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.4.272 · Cited by 67 · see citing works

Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin.

Mackiewicz, Z., Sukura, A., Povilenaité, D., Čeponis, A., Virtanen, I., Hukkanen, M., & Konttinen, Y. T. (2002) · PubMed · Cited by 66 · see citing works

Accumulation of Platelets at Sites of Antigen-Antibody-Mediated Injury: A Possible Role for IgE Antibody and Mast Cells

Kravis, T. C., & Henson, P. M. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.118.5.1569 · Cited by 66 · see citing works

Novel mode of action of iloprost: in vitro down-regulation of endothelial cell adhesion molecules

Bella, S. D., Molteni, M., Mocellin, C., Fumagalli, S., Bonara, P., & Scorza, R. (2001) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(01)00131-9 · Cited by 66 · see citing works

Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension

Iannone, F., Riccardi, M. T., Guiducci, S., Bizzoca, R., Cinelli, M., Matucci‐Cerinic, M., & Lapadula, G. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080424 · Cited by 65 · see citing works

Regulation of Connective Tissue Synthesis in Systemic Sclerosis

Varga, J., & Bashey, R. I. (1995) · International Reviews of Immunology · doi:10.3109/08830189509056712 · Cited by 63 · see citing works

Differential regulation of transcription and transcript stability of pro-α 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma

Eckes, B., Mauch, C., Hüppe, G., & Krieg, T. M. (1996) · Biochemical Journal · doi:10.1042/bj3150549 · Cited by 63 · see citing works

Use of Captopril as Early Therapy for Renal Scleroderma: A Prospective Study

Beckett, V. L., Donadío, J. V., BRENNAN, L. A., Conn, D. L., Osmundson, P. J., Chao, E. Y. S., & Holley, K. E. (1985) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60418-2 · Cited by 63 · see citing works

Increased tyrosine phosphorylation mediates the cooling‐induced contraction and increased vascular reactivity of Raynaud's disease

Furspan, P., Chatterjee, S., & Freedman, R. R. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20214 · Cited by 61 · see citing works

Activation of the Alternative Pathway of Human Complement by Apoptotic Human Umbilical Vein Endothelial Cells1

Tsuji, S., Kaji, K., & Nagasawa, S. (1994) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124598 · Cited by 61 · see citing works

Kidney Transplantation for Systemic Sclerosis Improves Survival and may Modulate Disease Activity

Gibney, E. M., Parikh, C. R., Jani, A. H., Fischer, M. J., Collier, D. H., & Wiseman, A. C. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00605.x · Cited by 57 · see citing works

Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis

Distler, J. H. W., & Distler, O. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken276 · Cited by 56 · see citing works

Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye

Swaney, J. S., Moreno, K. M., Gentile, A. M., Sabbadini, R. A., & STOLLER, G. L. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.07.005 · Cited by 56 · see citing works

ELEVATED von WILLEBRAND FACTOR ANTIGEN IN SYSTEMIC SCLEROSIS: RELATIONSHIP TO VISCERAL DISEASE

Greaves, M., Malía, R. G., Ward, A. M., Moult, J., Holt, C. M., Lindsey, N. J., Hughes, P. J., GOODFIEL, M., & Rowell, N. R. (1988) · Lara D. Veeken · doi:10.1093/rheumatology/27.4.281 · Cited by 53 · see citing works

Bone densitometry: Clinical considerations

Levis, S., & Altman, R. D. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199804)41:4 · Cited by 52 · see citing works

Hyperplasia of dermal microvascular pericytes in scleroderma*

Helmbold, P., Fiedler, E., Fischer, M. J., & Marsch, W. C. (2004) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2004.00203.x · Cited by 52 · see citing works

Renal Transplantation in Scleroderma

Chang, Y. J., & Spiera, H. (1999) · Medicine · doi:10.1097/00005792-199911000-00003 · Cited by 51 · see citing works

Targeting mediators of vascular injury in scleroderma

Schachna, L., & Wigley, F. M. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200211000-00010 · Cited by 49 · see citing works

Skin blood flow in patients with systemic sclerosis and Raynaud's phenomenon: effects of oral L-arginine supplementation.

Khan, F., & Belch, J. J. F. (1999) · PubMed · Cited by 49 · see citing works

Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy.

Freundlich, B., & Jiménez, S. A. (1987) · PubMed · Cited by 48 · see citing works

Regulator of G Protein Signaling 5: A New Player in Vascular Remodeling

Manzur, M., & Ganß, R. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.04.002 · Cited by 48 · see citing works

Le bosentan dans le traitement des ulcères digitaux évolutifs au cours de la sclérodermie systémique (9 cas)

Launay, D., Diot, É., Pasquier, É., Mouthon, L., Boullanger, N., Fain, O., Jégo, P., Carpentier, P., Hatron, P., & HACHULLA, E. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74645-0 · Cited by 48 · see citing works

Molecular aspects of scleroderma

Trojanowska, M. E. (2002) · Frontiers in bioscience · doi:10.2741/a798 · Cited by 46 · see citing works

Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis

Kuwana, M., Okazaki, Y., & Kaburaki, J. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0199-4 · Cited by 46 · see citing works

Labial capillary microscopy in systemic sclerosis.

Grassi, W., Core, P., Carlino, G., Blasetti, P., & Cervini, M. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.8.564 · Cited by 45 · see citing works

Digital ulcers and outcomes assessment in scleroderma

Matucci‐Cerinic, M., & Seibold, J. R. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken310 · Cited by 45 · see citing works

Platelets Exit Venules by a Transcellular Pathway at Sites of F–Met Peptide–Induced Acute Inflammation in Guinea Pigs

Feng, D., Nagy, J. A., Pyne, K., Dvorak, H. F., & Dvořàk, A. M. (1998) · International Archives of Allergy and Immunology · doi:10.1159/000023944 · Cited by 44 · see citing works

Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study

Furukawa, S., Yasuda, S., Amengual, O., Horita, T., Atsumi, T., & Koike, T. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.046870 · Cited by 43 · see citing works

Lysophosphatidic acid-induced arterial wall remodeling: Requirement of PPARγ but not LPA1 or LPA2 GPCR

Cheng, Y., Makarova, N., Tsukahara, R., Guo, H., Shuyu, E., Farrar, P. L., Balázs, L., Zhang, C., & Tigyi, G. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.08.003 · Cited by 41 · see citing works

Genetic factors in systemic sclerosis

Mayes, M. D., & Trojanowska, M. E. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2189 · Cited by 41 · see citing works

Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon

Furspan, P. (2005) · British journal of rheumatology · doi:10.1093/rheumatology/keh517 · Cited by 40 · see citing works

Role of T Cells and Cytokines in Effecting Fibrosis

Postlethwaite, A. E. (1995) · International Reviews of Immunology · doi:10.3109/08830189509056716 · Cited by 40 · see citing works

Soluble serum interleukin 2 receptors in patients with systemic sclerosis.

Steen, V. D., Engel, E. E., Charley, M. R., & Medsger, T. A. (1996) · PubMed · Cited by 40 · see citing works

B lymphocytes: Shedding new light on the pathogenesis of systemic sclerosis

Hasegawa, M. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00763.x · Cited by 39 · see citing works

The burden of pulmonary hypertension

Humbert, M. J. C. (2007) · European Respiratory Journal · doi:10.1183/09031936.00055407 · Cited by 39 · see citing works

Pathogenesis of Systemic Sclerosis

Pattanaik, D., Brown, M. A., Postlethwaite, B. C., & Postlethwaite, A. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00272 · Cited by 423 · see citing works

Steroidogenesis in the skin: Implications for local immune functions

Slominski, A., Zbytek, B., Nikolakis, G., Manna, P. R., Skobowiat, C., Zmijewski, M., Li, W., Janjetovic, Z., Postlethwaite, A., Zouboulis, C. C., et al. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.006 · Cited by 369 · see citing works

Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review

Ferreli, C., Gasparini, G., Parodi, A., Cozzani, E., Rongioletti, F., & Atzori, L. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8625-4 · Cited by 238 · see citing works

Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells

Μελισσαρόπουλος, Κ., Iliopoulos, G., Sakkas, L. I., & Daoussis, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.925741 · Cited by 119 · see citing works

The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist

Cipriani, P., Benedetto, P. D., Ruscitti, P., Capece, D., Zazzeroni, F., Liakouli, V., Pantano, I., Berardicurti, O., Carubbi, F., Pecetti, G., et al. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.150088 · Cited by 117 · see citing works

Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis

Maugeri, N., Franchini, S., Campana, L., Baldini, M., Ramirez, G. A., Sabbadini, M. G., Rovere, P. Q., & Manfredi, A. A. (2012) · Autoimmunity · doi:10.3109/08916934.2012.719946 · Cited by 114 · see citing works

Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions

Deegan, A. J., Talebi‐Liasi, F., Song, S., Li, Y., Xu, J., Men, S., Shinohara, M. M., Flowers, M. E. D., Lee, S. J., & Wang, R. K. (2018) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22788 · Cited by 113 · see citing works

Systemic sclerosis: Genetics and epigenetics

Luo, Y., Wang, Y., Wang, Q., Xiao, R., & Lu, Q. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.01.012 · Cited by 98 · see citing works

Interferon‐γ promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)‐1 and transforming growth factor (TGF) β2

Chrobak, I., Lenna, S., Stawski, L., & Trojanowska, M. E. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24337 · Cited by 93 · see citing works

Endothelium-mediated contributions to fibrosis

Sun, X., Nkennor, B., Mastikhina, O., Soon, K., & Nunes, S. S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.10.015 · Cited by 88 · see citing works

Endothelial Cells Recruit Macrophages and Contribute to a Fibrotic Milieu in Bleomycin Lung Injury

Leach, H., Chrobak, I., Han, R., & Trojanowska, M. E. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0152oc · Cited by 82 · see citing works

The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis

Zhou, Y., Hou, W., Xu, K., Han, D., Jiang, C., Mou, K., Li, Y., Meng, L., & Lu, S. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.12.008 · Cited by 67 · see citing works

Mean Platelet Volume Seems To Be a Valuable Marker in Patients with Systemic Sclerosis

Soydinç, S., Türkbeyler, İ. H., Pehlivan, Y., Soylu, G., Goktepe, F., Bilici, M. F., Zengin, O., Kısacık, B., & Onat, A. M. (2013) · Inflammation · doi:10.1007/s10753-013-9716-x · Cited by 64 · see citing works

Stress Doppler Echocardiography in Systemic Sclerosis: Evidence for a Role in the Prediction of Pulmonary Hypertension

Codullo, V., Caporali, R. F., Cuomo, G., Ghio, S., D’Alto, M., Fusetti, C., Borgogno, E., Montecucco, C., & Valentini, G. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38043 · Cited by 60 · see citing works

Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?

Colletti, M., Galardi, A., Santis, M. D., Guidelli, G. M., Giannatale, A. D., Luigi, L. D., & Antinozzi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184337 · Cited by 60 · see citing works

The Role of Micro RNA s in Autoimmune Diseases with Skin Involvement

Deng, X.-J., Su, Y., Wu, H., Wu, R., Zhang, P., Dai, Y., Chan, T. M., Zhao, M., & Lu, Q. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12261 · Cited by 56 · see citing works

Existing and novel biomarkers for precision medicine in systemic sclerosis

Wermuth, P. J., Piera-Velázquez, S., Rosenbloom, J., & Jiménez, S. A. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0021-9 · Cited by 56 · see citing works

T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review

Almeida, I., Silva, S. V., Fonseca, A. R., Silva, I., Vasconcelos, C., & Lima, M. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8505-8 · Cited by 51 · see citing works

The role of platelets in the pathogenesis of systemic sclerosis

Ramirez, G. A., Franchini, S., Rovere, P. Q., Sabbadini, M. G., Manfredi, A. A., & Maugeri, N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00160 · Cited by 46 · see citing works

Polymorphisms in STAT 4 and IRF 5 increase the risk of systemic sclerosis: a meta‐analysis

Xu, Y., Wang, W., Tian, Y., Liu, J., & Yang, R. (2015) · International Journal of Dermatology · doi:10.1111/ijd.12839 · Cited by 46 · see citing works

Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis

Muruganandam, M., Ariza‐Hutchinson, A., Patel, R. A., & Sibbitt, W. L. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s379815 · Cited by 47 · see citing works

Structural and functional failure of fibrillin‑1 in human diseases (Review)

Schrenk, S., Cenzi, C., Bertalot, T., Conconi, M. T., & Liddo, R. D. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3343 · Cited by 43 · see citing works

ANGPTL3: a novel biomarker and promising therapeutic target

Jiang, S., Qiu, G.-H., Zhu, N., Hu, Z., Liao, D., & Li, Q. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1566342 · Cited by 41 · see citing works

The role of endothelin and RAS/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications

Rokni, M., Shaker, M. S., Kavosi, H., Shokoofi, S., Mahmoudi, M., & Farhadi, E. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02787-w · Cited by 41 · see citing works

Dysregulation of angiogenic homeostasis in systemic sclerosis

Farouk, H. M., Hamza, S. H., Bakry, S. A. E., Youssef, S. S., Aly, I. M., Moustafa, A. A., Assaf, N. Y., & Dakrony, A. H. M. E. (2013) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12130 · Cited by 41 · see citing works

S1P/S1PR signaling pathway advancements in autoimmune diseases

Li, J., Huang, Y., Zhang, Y., Liu, P., Liu, M., Zhang, M., & Wu, R. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.9082 · Cited by 40 · see citing works

Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression

Sng, M. K., Chan, J. S. K., Teo, Z. Q., Phua, T., Tan, E. H. P., Wee, J. W. K., Koh, N. J. N., Tan, C. K., Chen, J. P., Pal, M., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0014-5 · Cited by 39 · see citing works

Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis

Hegner, B., Schaub, T., Catar, R. A., Kusch, A., Wagner, P., Essin, K., Lange, C., Riemekasten, G., & Dragun, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153101 · Cited by 38 · see citing works

Regulatory mechanisms of anthrax toxin receptor 1-dependent vascular and connective tissue homeostasis

Besschetnova, T. Y., Ichimura, T., Katebi, N., Croix, B. S., Bonventre, J. V., & Olsen, B. R. (2015) · Matrix Biology · doi:10.1016/j.matbio.2014.12.002 · Cited by 38 · see citing works

Neutrophil extracellular traps induce pyroptosis of pulmonary microvascular endothelial cells by activating the NLRP3 inflammasome

Zhao, P., Zhu, J., Bai, L., Ma, W., Li, F., Zhang, C., Zhao, L., Wang, L., & Zhang, S. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae028 · Cited by 36 · see citing works

Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications

Vito, C. D., Hadi, L. A., Navone, S. E., Marfia, G., Campanella, R., Mancuso, M. E., & Riboni, L. (2016) · Platelets · doi:10.3109/09537104.2016.1144179 · Cited by 35 · see citing works

Geniposide inhibited endothelial-mesenchymal transition via the mTOR signaling pathway in a bleomycin-induced scleroderma mouse model.

Qi, Q., Mao, Y., Tian, Y., Zhu, K., Cha, X., Wu, M., & Zhou, X. (2017) · PubMed Central · Cited by 35 · see citing works

Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro

Svegliati, S., Amico, D., Spadoni, T., Fischetti, C., Finke, D., Moroncini, G., Paolini, C., Tonnini, C., Grieco, A., Rovinelli, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00075 · Cited by 35 · see citing works

Macro- and microvascular disease in systemic sclerosis

Kavian, N., & Batteux, F. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.05.015 · Cited by 35 · see citing works

A review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathways

Jiménez, S. A., Mendoza, F. A., & Piera-Velázquez, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551911 · Cited by 34 · see citing works

Platelets in Skin Autoimmune Diseases

Liu, X., Gorzelanny, C., & Schneider, S. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01453 · Cited by 32 · see citing works

Epigenetics and pathogenesis of systemic sclerosis; the ins and outs

Aslani, S., Sobhani, S., Gharibdoost, F., Jamshidi, A., & Mahmoudi, M. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.01.003 · Cited by 31 · see citing works

Endothelial cell-specific activation of transforming growth factor-β signaling in mice induces cutaneous, visceral, and microvascular fibrosis

Wermuth, P. J., Carney, K. R., Mendoza, F. A., Piera-Velázquez, S., & Jiménez, S. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.23 · Cited by 30 · see citing works

Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosis

Huang, M., Tabib, T., Khanna, D., Assassi, S., Domsic, R. T., & Lafyatis, R. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-225415 · Cited by 26 · see citing works

Targeting interferons as a strategy for systemic sclerosis treatment

Ciechomska, M., & Skalska, U. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.10.011 · Cited by 25 · see citing works

Platelets, complement and tissue inflammation

Ioannou, A., Kannan, L., & Tsokos, G. C. (2012) · Autoimmunity · doi:10.3109/08916934.2012.722144 · Cited by 23 · see citing works

The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential

Kim, S., Park, H. J., & Lee, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416154 · Cited by 22 · see citing works

High prevalence of salivary gland ultrasound abnormalities in systemic sclerosis

Lee, K., Choi, W., Kim, J., & Kim, H. (2020) · Joint Bone Spine · doi:10.1016/j.jbspin.2020.105113 · Cited by 21 · see citing works

Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development

Pieri, A. D., Korman, B. D., Jüngel, A., & Wuertz‐Kozak, K. (2021) · Advanced Biology · doi:10.1002/adbi.202000168 · Cited by 22 · see citing works

Evaluation of endothelial dysfunction and clinical events in patients with early-stage vasculopathy in limited systemic sclerosis

Jud, P., Meinitzer, A., Strohmaier, H. M., Schwantzer, G., Foris, V., Kovács, G., Avian, A., Odler, B., Moazedi‐Fürst, F., Brodmann, M., et al. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/243mpp · Cited by 21 · see citing works

Association of Immunological Cell Profiles with Specific Clinical Phenotypes of Scleroderma Disease

López-Cacho, J. M., Gallardo, S., de la Paz, M. P., Aguerri, M., Calzada, D., Mayayo, T., González-Rodrı́guez, M. L., Rabasco, A. M., Lahoz, C., & Cárdaba, B. (2014) · BioMed Research International · doi:10.1155/2014/148293 · Cited by 21 · see citing works

Serum vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1) and sVEGFR-2 in systemic sclerosis patients: Relation to clinical manifestations and capillaroscopy findings

Shenavandeh, S., Tarakemeh, T., Sarvestani, E. K., & Nazarinia, M. A. (2016) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2016.03.004 · Cited by 19 · see citing works

The clinical effects of l _arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon

Curtiss, P., Schwager, Z. A., Sicco, K. L., & Franks, A. G. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15180 · Cited by 19 · see citing works

Previously undescribed pulpal and periodontal ligament calcifications in systemic sclerosis: a case report

Jung, S., Minoux, M., Manière, M., Martin, T., & Schmittbuhl, M. (2013) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2012.09.091 · Cited by 17 · see citing works

Oxidative/nitrative stress in the pathogenesis of systemic sclerosis: are antioxidants beneficial?

Ames, P. R. J., Bucci, T., Merashli, M., Amaral, M., Arcaro, A., Gentile, F., Nourooz‐Zadeh, J., & Alves, J. D. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1525712 · Cited by 16 · see citing works

Venous Thromboembolism in Systemic Sclerosis: Prevalence, Risk Factors, and Effect on Survival

Johnson, S. R., Hakami, N. T. M., Ahmad, Z., & Wijeysundera, D. N. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.170268 · Cited by 15 · see citing works

Learning from rejection: What transplantation teaches us about (other) vascular pathologies

Mitchell, R. N. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.05.006 · Cited by 13 · see citing works

Serotonin and systemic sclerosis. An emerging player in pathogenesis

Sagonas, I., & Daoussis, D. (2021) · Joint Bone Spine · doi:10.1016/j.jbspin.2021.105309 · Cited by 13 · see citing works

Assessment of hand superficial oxygenation during ischemia/reperfusion in healthy subjects versus systemic sclerosis patients by 2D near infrared spectroscopic imaging

Jalil, B., Hartwig, V., Salvetti, O., Potì, L., Gargani, L., Barskova, T., Matucci‐Cerinic, M., & L’Abbate, A. (2017) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2017.12.006 · Cited by 13 · see citing works

Novel investigational agents for the treatment of scleroderma

McMahan, Z. H., & Wigley, F. M. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.848852 · Cited by 12 · see citing works

A Genome‐Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome

Casares‐Marfil, D., Martínez‐Bueno, M., Borghi, M. O., Pons‐Estel, G., Reales, G., Zuo, Y., Espinosa, G., Radstake, T. R. D. J., van den Hoogen, L. L., Wallace, C., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42947 · Cited by 12 · see citing works

The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis

Colasanti, T., Stefanantoni, K., Fantini, C., Corinaldesi, C., Vasile, M., Marampon, F., Luigi, L. D., Antinozzi, C., Sgrò, P., Lenzi, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710150 · Cited by 12 · see citing works

Systemic vascular distensibility relates to exercise capacity in connective tissue disease

Singh, I., Oliveira, R. K. F., Naeije, R., Oldham, W. M., Faria‐Urbina, M., Waxman, A. B., & Systrom, D. M. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa510 · Cited by 12 · see citing works

Role of Alarmins in the Pathogenesis of Systemic Sclerosis

Giovannetti, A., Straface, E., Rosato, E., Casciaro, M., Pioggia, G., & Gangemi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144985 · Cited by 11 · see citing works

Effects of arterial blood on the venous blood vessel wall and differences in percentages of lymphocytes and neutrophils between arterial and venous blood

Peng, L., Juan, W., Yang, K., Zhao, S., Dai, J., Liang, Z., & Cao, Y. (2018) · Medicine · doi:10.1097/md.0000000000011201 · Cited by 10 · see citing works

Therapeutic molecular targets of SSc-ILD

Zhang, Y., & Distler, J. H. W. (2020) · Journal of Scleroderma and Related Disorders · doi:10.1177/2397198319899013 · Cited by 10 · see citing works

Effect of vasodilator and immunosuppressive therapy on the endothelial dysfunction in patients with systemic sclerosis

Bhattacharjee, D., Mondal, S., Saha, A., Misra, S., Chatterjee, S., Rao, A., Sarkar, A., Chatterjee, S., Sinhamahapatra, P., & Ghosh, A. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00845-w · Cited by 8 · see citing works

Two-Dimensional near Infrared Spectroscopic Imaging of the Hand to Assess Microvascular Abnormalities in Systemic Sclerosis: A Pilot Study

Hartwig, V., Marinelli, M., Gargani, L., Barskova, T., Trivella, M. G., Matucci‐Cerinic, M., & L’Abbate, A. (2015) · Journal of Near Infrared Spectroscopy · doi:10.1255/jnirs.1152 · Cited by 8 · see citing works

Pathophysiology in Systemic Sclerosis: Current Insights and Future Perspectives

Al-Gburi, S., Moinzadeh, P., & Krieg, T. (2025) · Sclerosis · doi:10.3390/sclerosis3020017 · Cited by 8 · see citing works

Successful wound healing of refractory digital ulcer in patient with systemic sclerosis by Waon therapy

Yamane, H., Araki, R., Doi, A., Sato, F., Tanaka, K., Miyazaki, N., Goda, T., & Yamada, T. (2021) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2021.04.001 · Cited by 7 · see citing works

Nonthrombotic proliferative vasculopathy associated with antiphospholipid antibodies: A case report and literature review

Lee, J. S., Kim, H., Lee, E. B., Song, Y. W., & Park, J. K. (2016) · Modern Rheumatology · doi:10.1080/14397595.2016.1218596 · Cited by 7 · see citing works

Pulmonary Hypertension Associated With Scleroderma and Connective Tissue Disease: Potential Molecular and Cellular Targets

Trojanowska, M. E. (2017) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-16.2.61 · Cited by 7 · see citing works

Outcomes of sympathectomy and vascular bypass for digital ischaemia in connective tissue disorders

Shammas, R. L., Hwang, B. H., Levin, L. S., Richard, M. J., Ruch, D. S., & Mithani, S. K. (2017) · Journal of Hand Surgery (European Volume) · doi:10.1177/1753193417718784 · Cited by 6 · see citing works

Biomarker discovery in systemic sclerosis: state of the art

Bonella, F., Patuzzo, G., & Lunardi, C. (2015) · Current Biomarker Findings · doi:10.2147/cbf.s60446 · Cited by 6 · see citing works

Corneal Perforation after Nd:YAG Capsulotomy: A Case Report and Literature Review

Khreish, M., Hanna, R., Berkovitz, L., & Tiosano, B. (2019) · Case Reports in Ophthalmology · doi:10.1159/000499178 · Cited by 6 · see citing works

The Epigenetic Regulation of Scleroderma and Its Clinical Application

Luo, Y., & Xiao, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3449-2_13 · Cited by 6 · see citing works

ERG Regulates Lymphatic Vessel Specification Genes and Its Deficiency Impairs Wound Healing‐Associated Lymphangiogenesis

Yamashita, T., Kaplan, U., Chakraborty, A., Marden, G., Gritli, S., Roh, D. S., Bujor, A. M., Trojanowski, M. A., Ligresti, G., Browning, J. L., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42944 · Cited by 5 · see citing works

Vascular Mechanisms of Systemic Sclerosis

Gote-Schniering, J., Maurer, B., & Distler, O. (2018) · Springer eBooks · doi:10.1007/978-3-319-98477-3_4 · Cited by 5 · see citing works

Spectrum of Cerebrovascular Disease in Scleroderma: A Case Series and Systematic Review

Rosso, M., Ramaswamy, S., Aharonoff, D., İnanç, M., & Levine, S. R. (2023) · Cerebrovascular Diseases · doi:10.1159/000533230 · Cited by 4 · see citing works

Stem cell-based therapy for systemic sclerosis

Moghaddam, M. Z., Mousavi, M. J., & Ghotloo, S. (2023) · Rheumatology Advances in Practice · doi:10.1093/rap/rkad101 · Cited by 4 · see citing works

Angiopoietin-like protein 2 mediates vasculopathy-driven fibrogenesis in a mouse model of systemic sclerosis

Saha, D., Annadorai, R. K., Thannimangalath, S., Shroff, N. P., Kataria, S., Dam, B., Dutta, A., Hegde, A., Hiwale, A. A., Ravula, V., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci177123 · Cited by 3 · see citing works

Predicting clinical events using Bayesian multivariate linear mixed models with application to scleroderma

Kim, J. S., Shah, A. A., Hummers, L. K., & Zeger, S. L. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01439-y · Cited by 3 · see citing works

The association between vibration and vascular injury in rheumatic diseases: A review of the literature

Wang, Y., Huang, X., Yan, J.-W., Wan, Y.-N., Wang, B., Tao, J., Chen, B., Li, B., Yang, G., & Wang, J. (2014) · Autoimmunity · doi:10.3109/08916934.2014.947477 · Cited by 3 · see citing works

Preclinical and Clinical Data on Current Therapeutic Options for Micro- and Macrovascular Abnormalities in Systemic Sclerosis

Bakopoulou, K., Kaouri, I. E., Siliogka, E., Siliogkas, P., Shumnalieva, R., & Velikova, T. V. (2024) · Sclerosis · doi:10.3390/sclerosis2040021 · Cited by 2 · see citing works

Prediction of scleroderma renal crisis in patients of SSc: insight from the CRDC cohort study

Huang, H., Xu, S., Li, H., Duan, X., Hui, M., Zhou, J., Zhang, L. J., Li, M., Zeng, X., & Xu, D. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf034 · Cited by 2 · see citing works

Vasculopatía de grandes vasos en la esclerosis sistémica

Segura, B. T., & Ferraz‐Amaro, I. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2014.12.016 · Cited by 2 · see citing works

Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis

Maciejewska, M., Stec, A., Zaremba, M., Maciejewski, C., Rudnicka, L., & Sikora, M. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s409490 · Cited by 2 · see citing works

How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients?

Correale, M., Bevere, E. M. L., Tricarico, L., Villani, D., Granato, M., Guerriero, E., Capasso, R., Rossi, L., Rotondo, C., Cantatore, F. P., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15081029 · Cited by 1 · see citing works

Separated or joint models of repeated multivariate data to estimate individuals’ disease trajectories with application to scleroderma

Kim, J. S., Shah, A. A., Hummers, L. K., & Zeger, S. L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320414 · Cited by 1 · see citing works

Necrotising pancreatitis in a patient with CREST syndrome: a rare autoimmune gastrointestinal complication

Hazzouri, A. A., Attieh, P., Ghaleb, G., Khalil, A., Chamchoum, N., Karam, K., & Fiani, E. (2025) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2025_005812 · Cited by 1 · see citing works

THE IMPACT OF ANTI B-CELL THERAPY ON ARTERIAL STIFFNESS IN SYSTEMIC SCLERODERMA

Maslyanskiy, А. L., Павловна, К. Е., Penin, I. N., Cheshuina, M. D., Lapin, S. V., & Конради, А. О. (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-3-212-220 · Cited by 1 · see citing works

Clinical Phenotype of Endothelial Dysfunction in Romanian Scleroderma Patients.

Groseanu, L., Berghea, F., Balanescu, A. R., Predețeanu, D., Bojinca, V. C., Saulescu, I. C., Constantinescu, C., Opriș-Belinski, D., Abobului, M., Borangiu, A., et al. (2016) · Europe PMC (PubMed Central) · Cited by 1 · see citing works

Associations of autoantibodies and clinical profile of the patients with systemic sclerosis

Mahmud, S., Choudhury, M. R., Bandhan, I. H., Islam, M. S., Shahin, M. A., Haq, S. A., & Zaman, M. M. (2022) · Rheumatology & autoimmunity · doi:10.1002/rai2.12053 · Cited by 1 · see citing works

Bosentan versus nifedipine in the treatment of vasculopathy in systemic sclerosis patients: A randomized control trial

Phát, T. N., Lượng, V. H., Minh, V. N., My, L. H., Phuong, H. T., Vinh, N. T. H., & Doanh, L. H. (2022) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-070722-1406 · Cited by 1 · see citing works

High mobility box protein-1 may be a new biomarker in active interstitial lung disease of systemic sclerosis

Yıldırım, D., Alp, G. T., Kilicarslan, H., Vasi, I., & Küçük, H. (2024) · Journal of Clinical and Experimental Investigations · doi:10.29333/jcei/14364 · Cited by 1 · see citing works

An Innovative Approach of Examining Skin Changes Associated with Scleroderma from a Mechanical Perspective, Stiffness based Novel Analysis

Saadoon, M. Z. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24107023010 · Cited by 1 · see citing works

Large vessels vasculopathy in systemic sclerosis

Segura, B. T., & Ferraz‐Amaro, I. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.04.007 · Cited by 1 · see citing works

Epigenetics and Fibrosis

Liu, B., Wang, X. S., Chen, H., Lu, Q., Gershwin, M. E., & Leung, P. S. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800957-4.00004-7 · Cited by 1 · see citing works

Sulodexide – unrealized potential in dermatology

Krasowska, D., Polkowska-Pruszyńska, B., & Michalak-Stoma, A. (2019) · Dermatology Review · doi:10.5114/dr.2019.83444 · Cited by 1 · see citing works

Microangiopathy in Inflammatory Diseases—Strategies in Surgery of the Lower Extremity

Biehl, C., Biehl, L., Tarner, I. H., Müller‐Ladner, U., Heiß, C., & Heinrich, M. (2022) · Life · doi:10.3390/life12020200 · Cited by 1 · see citing works

Reversible posterior leukoencephalopathy syndromeを合併した全身性強皮症の一例

知佐子, 鈴., 悠以, 清., 徹也, 田., 美琴子, 松., 元久, 山., 裕樹, 高., 正樹, 齊., & 恭久, 篠. (2013) · 臨床リウマチ · doi:10.14961/cra.25.34

Systemic Vasculitis in Various Organs of 33 Rheumatoid Arthritis and 11 Progressive Systemic Sclerosis Patients – A Comparative Postmortem Study

Bely, M. (2015) · Journal of Clinical Trials in Cardiology · doi:10.15226/2374-6882/2/2/00120

Análise ultraestrutural e implicação do RNA de interferência na fibrilogênese do colágeno V em pacientes com esclerodermia

de Morais, J. (2014) · doi:10.11606/t.5.2014.tde-09022015-122559

INFLAMMATORY MEDIATORS ROLE IN ATHEROSCLEROTIC LESION DEVELOPMENT IN THE LARGE ARTERIES IN PATIENTS WITH SYSTEMIC SCLERODERMIA

Maslyanskiy, А. L., Павловна, К. Е., Валерьевич, К. А., Vasilieva, E. Y., Penin, I. N., Rotar, О. P., Лазарева, Н. М., Lapin, S. V., Александрович, С. К., Солнцев, В. Н., et al. (2015) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2015-3-4-11

Patofisiologi kasus skleroderma pada disfagia esofagus

Liwikasari, N., & Muyassaroh, M. (2016) · Oto Rhino Laryngologica Indonesiana · doi:10.32637/orli.v46i1.152

A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis.

Pattanaik, D., & Postlethwaite, A. E. (2010) · PubMed · Cited by 29 · see citing works

The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity

Ko, J., Noviani, M., Chellamuthu, V. R., Albani, S., & Low, A. H. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814287 · Cited by 77 · see citing works

Macro- and microvascular disease in systemic sclerosis

Kavian, N., & Batteux, F. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.05.015 · Cited by 35 · see citing works

Targeting Vascular Disease in Systemic Sclerosis

Kowal‐Bielecka, O. (2006) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153006779025793 · Cited by 7 · see citing works

Vasculopathy in scleroderma

Asano, Y., & Sato, S. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0505-5 · Cited by 187 · see citing works